Medacta Group SA
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	CHF363.12M N/A	CHF437.12M 20.37%	CHF510.77M 16.85%	Avg: CHF665.47M Low: CHF656.94M High: CHF673.13M avg. 30.28%	Avg: CHF745.04M Low: CHF738.14M High: CHF752.65M avg. 11.95%	Avg: CHF802.58M Low: CHF795.15M High: CHF810.78M avg. 7.72%
Net Income % change YoY	CHF51.52M N/A	CHF46.24M -10.23%	CHF47.36M 2.40%	Avg: CHF84.61M Low: CHF77.41M High: CHF88.10M avg. 78.64%	Avg: CHF99.43M Low: CHF95.56M High: CHF109.21M avg. 17.51%	Avg: CHF115.71M Low: CHF114.32M High: CHF117.24M avg. 16.37%
EBITDA % change YoY	CHF97.81M N/A	CHF106.95M 9.34%	CHF119.64M 11.86%	Avg: CHF164.69M Low: CHF162.58M High: CHF166.58M avg. 37.65%	Avg: CHF184.38M Low: CHF182.67M High: CHF186.26M avg. 11.95%	Avg: CHF198.62M Low: CHF196.78M High: CHF200.65M avg. 7.72%
EPS % change YoY	$2.58 N/A	$2.32 -10.07%	$2.37 2.15%	Avg: $4.21 Low: $3.88 High: $4.42 avg. 77.71%	Avg: $5.04 Low: $4.79 High: $5.47 avg. 19.64%	Avg: $5.8 Low: $5.73 High: $5.88 avg. 15.08%
Operating Expenses % change YoY	CHF202.68M N/A	CHF247.14M 21.93%	CHF273.40M 10.62%	Avg: CHF331.40M Low: CHF327.15M High: CHF335.21M avg. 21.21%	Avg: CHF371.02M Low: CHF367.59M High: CHF374.81M avg. 11.95%	Avg: CHF399.68M Low: CHF395.98M High: CHF403.76M avg. 7.72%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 37.51% in 2025-2027.

We have gathered data from 6 analysts. Their low estimate is 77.41M, average is 84.61M and high is 88.10M.

Wall Street analysts forecast annual average revenue growth of 16.65% in 2025-2027.

We have gathered data from 7 analysts. Their low revenue estimate is CHF656.94M, average is CHF665.47M and high is CHF673.13M.

Wall Street analysts forecast annual average earnings growth of 37.48% in 2025-2027.

We have gathered data from 6 analysts. Their low earnings per share estimate is $3.88, average is $4.21 and high is CHF4.41.